Tumor necrosis factor identified in multiple sclerosis brain

doi:10.1084/jem.170.2.607

This Article

	Full Text (PDF, 424K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Hofman, F. M.
	Articles by Merrill, J. E.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Hofman, F. M.
	Articles by Merrill, J. E.


Social Bookmarking

	What's this?

ARTICLES

Tumor necrosis factor identified in multiple sclerosis brain

FM Hofman, DR Hinton, K Johnson and JE Merrill
Department of Pathology, University of Southern California School of Medicine, Los Angeles.

Frozen brain specimens from patients with multiple sclerosis (MS) and other neurologic diseases were analyzed using immunocytochemical techniques for the presence of TNF. In brain lesions in MS, and subacute sclerosing panencephalitis, TNF+ cells were demonstrated. At the lesion site in MS, TNF+ staining is associated with both astrocytes and macrophages. These observations were not made in Alzheimer's disease or normal brain tissue. The presence of TNF in MS lesions suggests a significant role for cytokines and the immune response in disease progression.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Decker, Y., McBean, G., Godson, C. (2009). Lipoxin A4 inhibits IL-1{beta}-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells. Am. J. Physiol. Cell Physiol. 296: C1420-C1427 [Abstract] [Full Text]
Yang, L., Anderson, D. E., Kuchroo, J., Hafler, D. A. (2008). Lack of TIM-3 Immunoregulation in Multiple Sclerosis. J. Immunol. 180: 4409-4414 [Abstract] [Full Text]
Plumb, J, McQuaid, S, Cross, A K, Surr, J, Haddock, G, Bunning, R A., Woodroofe, M N (2006). Upregulation of ADAM-17 expression in active lesions in multiple sclerosis. Mult Scler 12: 375-385 [Abstract]
Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., O'Callaghan, J. P. (2006). Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-{alpha}. FASEB J. 20: 670-682 [Abstract] [Full Text]
Rozenfeld, C., Martinez, R., Seabra, S., Sant'Anna, C., Goncalves, J. G. R., Bozza, M., Moura-Neto, V., De Souza, W. (2005). Toxoplasma gondii Prevents Neuron Degeneration by Interferon-{gamma}-Activated Microglia in a Mechanism Involving Inhibition of Inducible Nitric Oxide Synthase and Transforming Growth Factor-{beta}1 Production by Infected Microglia. Am. J. Pathol. 167: 1021-1031 [Abstract] [Full Text]
Richez, C., Blanco, P., Lagueny, A., Schaeverbeke, T., Dehais, J. (2005). Neuropathy resembling CIDP in patients receiving tumor necrosis factor-{alpha} blockers. Neurology 64: 1468-1470 [Abstract] [Full Text]
Walker, J. E, Giri, S. N, Margolin, S. B (2005). A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis. Mult Scler 11: 149-158 [Abstract]
Huang, Y.-M., Liu, X., Steffensen, K., Sanna, A., Arru, G., Fois, M. L., Rosati, G., Sotgiu, S., Link, H. (2005). Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden. Mult Scler 11: 16-23 [Abstract]
Horneff, G, Schmeling, H, Biedermann, T, Foeldvari, I, Ganser, G, Girschick, H J, Hospach, T, Huppertz, H I, Keitzer, R, Kuster, R M, Michels, H, Moebius, D, Rogalski, B, Thon, A, for the Paediatric Rheumatology Collaborative Grou, (2004). The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 63: 1638-1644 [Abstract] [Full Text]
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., Platsoucas, C. D. (2004). Theiler's Virus Infection: a Model for Multiple Sclerosis. Clin. Microbiol. Rev. 17: 174-207 [Abstract] [Full Text]
Jolicoeur, P., Hu, C., Mak, T. W., Martinou, J.-C., Kay, D. G. (2003). Protection against Murine Leukemia Virus-Induced Spongiform Myeloencephalopathy in Mice Overexpressing Bcl-2 but Not in Mice Deficient for Interleukin-6, Inducible Nitric Oxide Synthetase, ICE, Fas, Fas Ligand, or TNF-R1 Genes. J. Virol. 77: 13161-13170 [Abstract] [Full Text]
Shemi, D., Azab, A., Kaplanski, J. (2003). The effect of high and low ambient temperatures on PGE2 and TNF-{alpha} production by rat glial brain cultures. Innate Immunity 9: 165-168 [Abstract]
Rozenfeld, C., Martinez, R., Figueiredo, R. T., Bozza, M. T., Lima, F. R. S., Pires, A. L., Silva, P. M., Bonomo, A., Lannes-Vieira, J., De Souza, W., Moura-Neto, V. (2003). Soluble Factors Released by Toxoplasma gondii-Infected Astrocytes Down-Modulate Nitric Oxide Production by Gamma Interferon-Activated Microglia and Prevent Neuronal Degeneration. Infect. Immun. 71: 2047-2057 [Abstract] [Full Text]
Koehler, N. K. U., Genain, C. P., Giesser, B., Hauser, S. L. (2002). The Human T Cell Response to Myelin Oligodendrocyte Glycoprotein: A Multiple Sclerosis Family-Based Study. J. Immunol. 168: 5920-5927 [Abstract] [Full Text]
Yang, L., Lindholm, K., Konishi, Y., Li, R., Shen, Y. (2002). Target Depletion of Distinct Tumor Necrosis Factor Receptor Subtypes Reveals Hippocampal Neuron Death and Survival through Different Signal Transduction Pathways. J. Neurosci. 22: 3025-3032 [Abstract] [Full Text]
May, L-A, Huang, Q, Morris, D, Danis, V, Manolios, N (2002). Relationship of tumour necrosis factor alpha gene polymorphisms and neuropsychiatric lupus. Lupus 11: 114-118 [Abstract]
Lindberg, R. L. P., De Groot, C. J. A., Montagne, L., Freitag, P., van der Valk, P., Kappos, L., Leppert, D. (2001). The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124: 1743-1753 [Abstract] [Full Text]
Sairanen, T., Carpen, O., Karjalainen-Lindsberg, M.-L., Paetau, A., Turpeinen, U., Kaste, M., Lindsberg, P. J., Cechetto, D. F. (2001). Evolution of Cerebral Tumor Necrosis Factor-{alpha} Production During Human Ischemic Stroke Editorial Comment. Stroke 32: 1750-1758 [Abstract] [Full Text]
Kadhim, H., Tabarki, B., Verellen, G., De Prez, C., Rona, A.-M., Sebire, G. (2001). Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 56: 1278-1284 [Abstract] [Full Text]
Probert, L., Eugster, H.-P., Akassoglou, K., Bauer, J., Frei, K., Lassmann, H., Fontana, A. (2000). TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 123: 2005-2019 [Abstract] [Full Text]
Pelfrey, C. M., Rudick, R. A., Cotleur, A. C., Lee, J.-C., Tary-Lehmann, M., Lehmann, P. V. (2000). Quantification of Self-Recognition in Multiple Sclerosis by Single-Cell Analysis of Cytokine Production. J. Immunol. 165: 1641-1651 [Abstract] [Full Text]
Lucotte, G., Bathelier, C., Mercier, G. (2000). TNF-{alpha} polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele all is associated with the disease in French patients. Mult Scler 6: 78-80 [Abstract]
Croxford, J. L., Triantaphyllopoulos, K. A., Neve, R. M., Feldmann, M., Chernajovsky, Y., Baker, D. (2000). Gene Therapy for Chronic Relapsing Experimental Allergic Encephalomyelitis Using Cells Expressing a Novel Soluble p75 Dimeric TNF Receptor. J. Immunol. 164: 2776-2781 [Abstract] [Full Text]
Bonetti, B., Stegagno, C., Cannella, B., Rizzuto, N., Moretto, G., Raine, C. S. (1999). Activation of NF-{kappa}B and c-jun Transcription Factors in Multiple Sclerosis Lesions : Implications for Oligodendrocyte Pathology. Am. J. Pathol. 155: 1433-1438 [Abstract] [Full Text]
Jurewicz, A. M., Walczak, A. K., Selmaj, K. W. (1999). Shedding of TNF receptors in multiple sclerosis patients. Neurology 53: 1409-1409 [Abstract] [Full Text]
Huang, W.-X., Huang, P., Link, H., Hillert, J. (1999). Cytokine analysis in multiple sclerosis by competitive RT - PCR: A decreased expression of IL-10 and an increased expression of TNF-{alpha} in chronic progression. Mult Scler 5: 342-348 [Abstract]
Venters, H. D., Tang, Q., Liu, Q., VanHoy, R. W., Dantzer, R., Kelley, K. W. (1999). A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc. Natl. Acad. Sci. USA 96: 9879-9884 [Abstract] [Full Text]
Arnason, (1999). TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study. Neurology 53: 457-457 [Abstract] [Full Text]
Armstrong, M A, McDonnell, G V, Graham, C A, Kirk, C W, Droogan, A G, Hawkins, S A (1999). Relationship between tumour necrosis factor-alpha (TNF{alpha}) production and a specific multiple sclerosis (MS) associated TNF gene haplotype. Mult Scler 5: 165-170 [Abstract]
Weiss, J. M., Downie, S. A., Lyman, W. D., Berman, J. W. (1998). Astrocyte-Derived Monocyte-Chemoattractant Protein-1 Directs the Transmigration of Leukocytes Across a Model of the Human Blood-Brain Barrier. J. Immunol. 161: 6896-6903 [Abstract] [Full Text]
Bright, J. J., Du, C., Coon, M., Sriram, S., Klaus, S. J. (1998). Prevention of Experimental Allergic Encephalomyelitis via Inhibition of IL-12 Signaling and IL-12-Mediated Th1 Differentiation: An Effect of the Novel Anti-Inflammatory Drug Lisofylline. J. Immunol. 161: 7015-7022 [Abstract] [Full Text]
Stalder, A. K., Carson, M. J., Pagenstecher, A., Asensio, V. C., Kincaid, C., Benedict, M., Powell, H. C., Masliah, E., Campbell, I. L. (1998). Late-Onset Chronic Inflammatory Encephalopathy in Immune-Competent and Severe Combined Immune-Deficient (SCID) Mice with Astrocyte-Targeted Expression of Tumor Necrosis Factor. Am. J. Pathol. 153: 767-783 [Abstract] [Full Text]
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G., Probert, L. (1998). Oligodendrocyte Apoptosis and Primary Demyelination Induced by Local TNF/p55TNF Receptor Signaling in the Central Nervous System of Transgenic Mice : Models for Multiple Sclerosis with Primary Oligodendrogliopathy. Am. J. Pathol. 153: 801-813 [Abstract] [Full Text]
Liu, J. S. H., Amaral, T. D., Brosnan, C. F., Lee, S. C. (1998). IFNs Are Critical Regulators of IL-1 Receptor Antagonist and IL-1 Expression in Human Microglia. J. Immunol. 161: 1989-1996 [Abstract] [Full Text]
Lassmann, H. (1998). Neuropathology in multiple sclerosis: new concepts. Mult Scler 4: 93-98 [Abstract]
Sharief, M K (1998). Cytokines in multiple sclerosis: pro-inflammation or pro-remyelination?. Mult Scler 4: 169-173 [Abstract]
Martiney, J. A., Rajan, A. J., Charles, P. C., Cerami, A., Ulrich, P. C., Macphail, S., Tracey, K. J., Brosnan, C. F. (1998). Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by CNI-1493, a Macrophage-Deactivating Agent. J. Immunol. 160: 5588-5595 [Abstract] [Full Text]
McManus, C. M., Brosnan, C. F., Berman, J. W. (1998). Cytokine Induction of MIP-1{alpha} and MIP-1{beta} in Human Fetal Microglia. J. Immunol. 160: 1449-1455 [Abstract] [Full Text]
Wolswijk, G. (1998). Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells. J. Neurosci. 18: 601-609 [Abstract] [Full Text]
Vora, A., Kidd, D., Miller, D., Perkin, G., Hughes, R., Ellis, B., Dumonde, D., Brown, K. (1997). Lymphocyte-endothelial cell interactions in multiple sclerosis: disease specificity and relationship to circulating tumour necrosis factor-{alpha} and soluble adhesion molecules. Mult Scler 3: 171-179 [Abstract]
Shen, Y., Li, R., Shiosaki, K. (1997). Inhibition of p75 Tumor Necrosis Factor Receptor by Antisense Oligonucleotides Increases Hypoxic Injury and beta -Amyloid Toxicity in Human Neuronal Cell Line. J. Biol. Chem. 272: 3550-3553 [Abstract] [Full Text]
Spranger, M., Fontana, A. (1996). REVIEW {blacksquare} : Activation of Microglia: A Dangerous Interlude in Immune Function in the Brain. Neuroscientist 2: 293-299 [Abstract]
Byskosh, P., Reder, A. (1996). Interferon {beta}-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Mult Scler 1: 262-269 [Abstract]
Sandberg-Wollheim, M, Ciusani, E, Salmaggi, A, Pociot, F (1995). An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis. Mult Scler 1: 181-185 [Abstract]
Kleiman, M., Brunquell, P. (1995). Acute Disseminated Encephalomyelitis: Response to Intravenous Immunoglobulin?. J Child Neurol 10: 481-483
Canto, M. D., Melvold, R., Kim, B. (1995). A hybrid between a resistant and a susceptible strain of mouse alters the pattern of Theiler's murine encephalomyelitis virus-induced white matter disease and favors oligodendrocyte-mediated remyelination. Mult Scler 1: 95-103 [Abstract]
McLaurin, J, Antel, J., Yong, V. (1995). Immune and non-immune actions of interferon-{beta}-1b on primary human neural cells. Mult Scler 1: 10-19 [Abstract]
Heumann, D., Gallay, P., Barras, C., Albrecht, H., de Flaugergues, J.C., Steck, A., Glauser, M.P. (1995). Lipopolysaccharide binding protein (LBP) as a marker of protein leakage in cerebrospinal fluid. Innate Immunity 2: 1-7 [Abstract]
Hollsberg, P., Hafler, D. A. (1993). Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection. NEJM 328: 1173-1182 [Full Text]
Louis, J., Magal, E, Takayama, S, Varon, S (1993). CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259: 689-692 [Abstract]
Ransohoff, R. M., Estes, M. L. (1991). Astrocyte Expression of Major Histocompatibility Complex Gene Products in Multiple Sclerosis Brain Tissue Obtained by Stereotactic Biopsy. Arch Neurol 48: 1244-1246 [Abstract]
Sinha, A., Lopez, M., McDevitt, H. (1990). Autoimmune diseases: the failure of self tolerance. Science 248: 1380-1388 [Abstract]
Eugenin, E. A., Eckardt, D., Theis, M., Willecke, K., Bennett, M. V. L., Saez, J. C. (2001). Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha. Proc. Natl. Acad. Sci. USA 98: 4190-4195 [Abstract] [Full Text]